DE69729798D1 - Therapeutische behandlung von vegf-bedingten augenkrankheiten - Google Patents
Therapeutische behandlung von vegf-bedingten augenkrankheitenInfo
- Publication number
- DE69729798D1 DE69729798D1 DE69729798T DE69729798T DE69729798D1 DE 69729798 D1 DE69729798 D1 DE 69729798D1 DE 69729798 T DE69729798 T DE 69729798T DE 69729798 T DE69729798 T DE 69729798T DE 69729798 D1 DE69729798 D1 DE 69729798D1
- Authority
- DE
- Germany
- Prior art keywords
- vegf
- therapeutic treatment
- eye diseases
- related eye
- protein kinase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1665896P | 1996-05-01 | 1996-05-01 | |
US16658P | 1996-05-01 | ||
US08/841,739 US6114320A (en) | 1996-05-01 | 1997-04-30 | Therapeutic treatment for VEGF related ocular diseases |
US841739 | 1997-04-30 | ||
PCT/US1997/007800 WO1997040831A1 (en) | 1996-05-01 | 1997-05-01 | Therapeutic treatment for vegf related occular diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69729798D1 true DE69729798D1 (de) | 2004-08-12 |
DE69729798T2 DE69729798T2 (de) | 2005-08-25 |
Family
ID=26688915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69729798T Expired - Lifetime DE69729798T2 (de) | 1996-05-01 | 1997-05-01 | Therapeutische behandlung von vegf-bedingten augenkrankheiten |
Country Status (22)
Country | Link |
---|---|
US (1) | US6114320A (de) |
EP (1) | EP0918519B1 (de) |
JP (1) | JP4122060B2 (de) |
KR (1) | KR100364487B1 (de) |
CN (1) | CN1158073C (de) |
AT (1) | ATE270548T1 (de) |
AU (1) | AU724923B2 (de) |
BR (1) | BR9710705A (de) |
CA (1) | CA2253613C (de) |
CZ (1) | CZ296711B6 (de) |
DE (1) | DE69729798T2 (de) |
EA (1) | EA001752B1 (de) |
ES (1) | ES2224249T3 (de) |
HK (1) | HK1020017A1 (de) |
HU (1) | HU226378B1 (de) |
IL (1) | IL126836A (de) |
NO (1) | NO322209B1 (de) |
NZ (2) | NZ332833A (de) |
PL (1) | PL189020B1 (de) |
PT (1) | PT918519E (de) |
UA (1) | UA54427C2 (de) |
WO (1) | WO1997040831A1 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5723456A (en) * | 1993-12-07 | 1998-03-03 | Eli Lilly & Company | Therapeutic treatment for cardiovascular diseases |
US6093740A (en) * | 1997-04-30 | 2000-07-25 | Eli Lilly And Company | Therapeutic treatment for skin disorders |
EP1105136B1 (de) * | 1998-08-13 | 2007-08-29 | Novartis AG | Verfahren zur behandlung von okularen neovaskularen erkrankungen |
US6214819B1 (en) | 1998-11-23 | 2001-04-10 | Novartis Ag | Method for treating ocular neovascular diseases |
CN1172673C (zh) * | 1998-11-23 | 2004-10-27 | 诺瓦提斯公司 | 星形孢菌素衍生物在制备治疗眼睛新血管生成性疾病的药物中的应用 |
ATE300957T1 (de) * | 1998-12-22 | 2005-08-15 | Genentech Inc | Antagonisten von vaskular-endothelialen zellwachstumsfaktoren und ihre anwendung |
US6271233B1 (en) | 1999-08-10 | 2001-08-07 | Ciba Vision Corporation | Method for treating ocular neovascular diseases |
US6921763B2 (en) | 1999-09-17 | 2005-07-26 | Abbott Laboratories | Pyrazolopyrimidines as therapeutic agents |
IL151045A0 (en) | 2000-02-07 | 2003-04-10 | Abbott Gmbh & Co Kg | 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |
MXPA03008560A (es) | 2001-03-22 | 2004-06-30 | Abbot Gmbh & Co Kg | Pirazolopirimidinas como agentes terapeuticos. |
US20020165158A1 (en) * | 2001-03-27 | 2002-11-07 | King George L. | Methods of modulating angiogenesis |
US20030119812A1 (en) * | 2001-11-08 | 2003-06-26 | Brazzell Romulus Kimbro | Method for decreasing capillary permeability in the retina |
US20030236246A1 (en) * | 2002-04-30 | 2003-12-25 | Brazzell Romulus Kimbro | Method for decreasing capillary permeability in the retina |
JP2005536516A (ja) * | 2002-07-23 | 2005-12-02 | ノバルティス アクチエンゲゼルシャフト | 薬剤、軟膏基剤および可溶化剤/分散剤を含む、眼科用軟膏組成物 |
EP1635842A4 (de) * | 2003-06-20 | 2007-04-04 | Alcon Inc | Behandlung von amd mit einer kombination von inhaltsstoffen |
CA2601278C (en) * | 2004-03-17 | 2014-06-10 | Lars Michael Larsen | Prevention of retinopathy by inhibition of the visual cycle |
EP1740591B1 (de) | 2004-04-02 | 2009-06-17 | OSI Pharmaceuticals, Inc. | Mit einem 6,6-bicyclischen ring substituierte heterobicyclische proteinkinaseinhibitoren |
TW200613306A (en) | 2004-07-20 | 2006-05-01 | Osi Pharm Inc | Imidazotriazines as protein kinase inhibitors |
AR057960A1 (es) | 2005-12-02 | 2007-12-26 | Osi Pharm Inc | Inhibidores de proteina quinasa biciclicos |
US7455447B2 (en) * | 2006-05-19 | 2008-11-25 | Mediatek Inc. | Method and apparatus for a portable device |
WO2008024734A2 (en) * | 2006-08-23 | 2008-02-28 | Novartis Ag | Use of pkc inhibitors in particular indolylmaleimide derivatives in ocular diseases |
WO2008042399A2 (en) * | 2006-10-03 | 2008-04-10 | The Trustees Of The University Of Pennsylvania | Method for treatment of macular degeneration |
JP6726734B2 (ja) | 2015-03-26 | 2020-07-22 | アイコー,エルエルシー | 画像解析のためのシステム |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ227850A (en) * | 1988-02-10 | 1991-11-26 | Hoffmann La Roche | Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders |
UA44690C2 (uk) * | 1993-12-07 | 2002-03-15 | Елі Ліллі Енд Компані | Макроциклічна сполука іміду біс-індол-малеїнової кислоти, спосіб її одержання та фармацевтична композиція, макроциклічні сполуки іміду біс-індол-малеїнової кислоти та біс-індол-малеїнового ангідриду, спосіб одержання (варіанти) |
US5624949A (en) * | 1993-12-07 | 1997-04-29 | Eli Lilly And Company | Protein kinase C inhibitors |
JPH07238044A (ja) * | 1993-12-07 | 1995-09-12 | Eli Lilly & Co | ビスインドリルマレイミドの改良合成法 |
US5545636A (en) * | 1993-12-23 | 1996-08-13 | Eli Lilly And Company | Protein kinase C inhibitors |
US5491242A (en) * | 1994-06-22 | 1996-02-13 | Eli Lilly And Company | Protein kinase C inhibitors |
US5481003A (en) * | 1994-06-22 | 1996-01-02 | Eli Lilly And Company | Protein kinase C inhibitors |
-
1997
- 1997-01-05 UA UA98116304A patent/UA54427C2/uk unknown
- 1997-04-30 US US08/841,739 patent/US6114320A/en not_active Expired - Lifetime
- 1997-05-01 NZ NZ332833A patent/NZ332833A/en unknown
- 1997-05-01 CN CNB971956995A patent/CN1158073C/zh not_active Expired - Fee Related
- 1997-05-01 AU AU29361/97A patent/AU724923B2/en not_active Ceased
- 1997-05-01 NZ NZ538109A patent/NZ538109A/en not_active IP Right Cessation
- 1997-05-01 PT PT97923594T patent/PT918519E/pt unknown
- 1997-05-01 WO PCT/US1997/007800 patent/WO1997040831A1/en active IP Right Grant
- 1997-05-01 HU HU9902805A patent/HU226378B1/hu not_active IP Right Cessation
- 1997-05-01 CZ CZ0349998A patent/CZ296711B6/cs not_active IP Right Cessation
- 1997-05-01 EP EP97923594A patent/EP0918519B1/de not_active Expired - Lifetime
- 1997-05-01 DE DE69729798T patent/DE69729798T2/de not_active Expired - Lifetime
- 1997-05-01 AT AT97923594T patent/ATE270548T1/de active
- 1997-05-01 CA CA002253613A patent/CA2253613C/en not_active Expired - Fee Related
- 1997-05-01 EA EA199800970A patent/EA001752B1/ru not_active IP Right Cessation
- 1997-05-01 KR KR10-1998-0708799A patent/KR100364487B1/ko not_active IP Right Cessation
- 1997-05-01 BR BR9710705A patent/BR9710705A/pt not_active Application Discontinuation
- 1997-05-01 PL PL97330463A patent/PL189020B1/pl not_active IP Right Cessation
- 1997-05-01 JP JP53929897A patent/JP4122060B2/ja not_active Expired - Fee Related
- 1997-05-01 ES ES97923594T patent/ES2224249T3/es not_active Expired - Lifetime
- 1997-05-01 IL IL12683697A patent/IL126836A/en not_active IP Right Cessation
-
1998
- 1998-10-30 NO NO19985067A patent/NO322209B1/no not_active IP Right Cessation
-
1999
- 1999-11-19 HK HK99105357A patent/HK1020017A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69729798D1 (de) | Therapeutische behandlung von vegf-bedingten augenkrankheiten | |
EA199800971A1 (ru) | Способ лечения новообразований, вкючающий применение ингибиторов протеиназы с | |
EA200602015A1 (ru) | Гуманизированные антитела, распознающие бета-амилоидный пептид | |
DK0867184T3 (da) | Anvendelse af tiagabin til behandling af søvnforstyrrelser | |
ATE201992T1 (de) | Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen | |
DE69834724D1 (de) | Behandlung von Darm- oder Blasenentzündungen | |
ATE315933T1 (de) | Therapeutische behandlung von kardiovaskularen krankheiten | |
DE69710333D1 (de) | Cyclopentan(en)säure-2-alkenyl-derivate als therapeutika in der behandlung der okulären hypertonie | |
ATE210981T1 (de) | Verwendung von pkc-hemmern zur herstellung eines arzneimittels zur behandlung von sexualfunktionsstörungen | |
DE69739190D1 (de) | Arzneimittel zur behandlung von oculären kreislauferkrankungen | |
EA199900245A1 (ru) | Использование ингибиторов протеинкиназы с для получения лекарственного препарата для лечения спида | |
EP0940141A3 (de) | Verwendung von PKC-Inhibitoren zur Herstellung eines Arzneimittels zur Behandlung von Cytomegalovirusinfektionen | |
EP0940143A3 (de) | Verwendung von PKC-Inhibitoren zur Herstellung eines Arzneimittels zur Behandlung von Asthma | |
DE69421705D1 (de) | Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen | |
ATE360416T1 (de) | Bis-indolylmaleimide zur therapeutischen behandlung von nieren-funktionsstörungen | |
NO990947L (no) | Anvendelse av inhibitorer for PKC til fremstilling av et medikament for behandling av sentralnervesystemsykdommer forbundet med HIV-infeksjon | |
HUP9903911A2 (hu) | PKC inhibitorok alkalmazása a központi idegrendszer HIV-fertőzéssel kapcsolatos megbetegedéseinek kezelésére szolgáló gyógyászati készítmények előállítására | |
RU98111356A (ru) | Способ лечения ожогового шока | |
NO990948L (no) | Anvendelse av PKC-inhibitorer til fremstilling av et medikament for behandling av HTLV-1-infeksjoner |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336 |
|
8328 | Change in the person/name/address of the agent |
Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN |